On the other hand, in cirrhotic NAFLD patients (LC, F4) with HCC, serum YKL-40 levels were not significantly different from those without HCC (Fig. 4a). This evidence concerns the gene CHI3L1 and metabolic dysfunction-associated steatotic liver disease.